ITI Pharma and Healthcare Fund Regular vs HDFC Pharma and Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹166 Cr | ₹828 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 05 Oct 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open-ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | % |
| Expense Ratio | 2.34 | 2.29 |
| Manager | Rohan Korde | Dhruv Muchhal |
| ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
| Exits Load | Exit load of 1% if redeemed within 12 months./365 | Exit load of 1%, if redeemed within 30 days./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | -2.79% | -2.06% |
| 6 Month | 21.52% | 25.69% |
| 1 Year | 43.77% | 50.6% |
| 3 Year | 18.29% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 40.97% | 51.55% |
| 3 Year | - | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 20.74% | 62.28% |
| 3 Year | 19.19% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 14.52% | - |
| Sharp | - | - |
| Beta | - | - |
| Alpha | - | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Dhruv Muchhal |
| Total AUM | ₹4626 Cr | ₹520687 Cr |
| Fund Manage | 10 | 40 |
| ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 0.48 | 1.98 |
| Mid Cap | 28.05 | 32.4 |
| Small Cap | 32.19 | 33.12 |
| Large Cap | 39.28 | 32.5 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 0.48 | 1.98 |
| Healthcare | 96.77 | - |
| Chemicals | 2.75 | - |
| Pharmaceuticals & Biotechnology | - | 74.71 |
| Healthcare Services | - | 22.28 |
| Retailing | - | 1.03 |
Top Comparisons
SBI International Access - US Equity FoF - Regular Plan - Growth
3Y Returns11.71%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns11.03%
Aditya Birla Sun Life Medium Term Plan - Growth - Regular Plan
3Y Returns13.52%
DSP Bond Fund - Growth
3Y Returns5.73%
Franklin India Government Securities Fund - Growth
3Y Returns4.84%
Edelweiss Government Securities Fund - Regular Plan - Growth Option
3Y Returns5.79%
SBI Corporate Bond Fund - Regular Plan - Growth
3Y Returns5.73%
Sundaram Corporate Bond Fund Regular Plan- Growth
3Y Returns5.77%